Because there is an overlap between the clinical and molecular characteristics of MUTYH-associated tumor syndrome and Lynch syndrome, underlying constitutional variants in MMR genes must be ruled out before considering MUTYH deficiency as potential diagnosis. The gene discussed is MUTYH; the disease is neoplastic syndrome.